Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_assertion type Assertion NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_head.
- NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_assertion description "[RAR-beta2 expression was studied by reverse transcription-polymerase chain reaction (RT-PCR) analysis in eight breast cancer cell lines that were either treated with the demethylating agent 5-aza-2'-deoxycytidine and subsequently with all-trans-retinoic acid (ATRA) or left untreated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_provenance.
- NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_assertion evidence source_evidence_literature NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_provenance.
- NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_assertion SIO_000772 10814678 NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_provenance.
- NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_assertion wasDerivedFrom befree-2016 NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_provenance.
- NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_assertion wasGeneratedBy ECO_0000203 NP284127.RAAHA-znEIeBDGm3878iZn6oZG1B_IV7Z9qLNLV7BgX_Y130_provenance.